autologous CD34+ hematopoietic stem cells (Immunovec)

N/A

Report date: 2025/01/26 17:00:13

Base Information

Drug Nameautologous CD34+ hematopoietic stem cells (Immunovec)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Hematopoietic stem cells therapy
Mechanisms of ActionForkhead box protein P3 stimulants
TargetsForkhead box protein P3
Therapy Area/IndicationsAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesImmunoVec Inc
China Registration ClassN/A

Develop Information

Active CompaniesImmunoVec Inc
Inactive CompaniesN/A
Active IndicationsAutoimmune Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A